GLP-1 Receptor Agonists Linked to Fewer Amputations, but Wound-Healing Claims Remain Unproven
A 2026 review associates GLP-1 receptor agonists with fewer amputations and foot ulcers, while wound healing and neuropathy benefits remain investigational.